University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Teresa M. Darragh, M.D.


Dr. Teresa M. Darragh is a pathologist who sees patients in the Cytology Service and Dysplasia Clinic. She specializes in human papilloma virus (HPV) induced anogenital neoplasia, which includes cervical and anal cancer. She is involved in research investigating HPV-related anogenital tract disease in men and women. UCSF's team of experts has been fundamental in the recognition of anal HPV-related disease and the acceptance of anal cytology as a screening tool for HPV at-risk populations.

Darragh received an medical degree at Cornell University Medical College in New York. She completed a pathology residency, followed by fellowships in surgical pathology and cytopathology at UCSF. Darragh is a member of several professional organizations, including the American Society of Clinical Pathologists, Papanicolaou Society of Cytopathology, American Society of Cytopathology, American Society for Colposcopy and Cervical Pathology (ASCCP), and the College of American Pathologists. She has received numerous honors and awards, including ASCCP's Meritorious Award of Scientific Achievement. She is a professor of clinical pathology at UCSF.

More about Teresa M. Darragh


Cornell University 1986


UCSF, Pathology 1988


UCSF, Cytopathology 1990
UCSF, Surgical Pathology 1991

Selected Research and Publications

  1. Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, Chiao E, Einstein MH, Goldstone SE, Jay N, Likes WM, Stier EA, Welton ML, Wiley DJ, Palefsky JM. Screening for Anal Cancer in Women. J Low Genit Tract Dis. 2015 Jul; 19(3 Suppl 1):S26-41.
  2. Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, Ocampo R, Schussler J, Lowy D, Guillen D, Stoler MH, Quint W, Morales J, Avila C, Rodriguez AC, Kreimer AR. Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. Vaccine. 2015 Apr 27; 33(18):2141-51.
  3. Heard I, Etienney I, Potard V, Poizot-Martin I, Moore C, Lesage AC, Ressiot E, Crenn-Hebert C, Fléjou JF, Cubie H, Costagliola D, Darragh TM. High Prevalence of Anal Human Papillomavirus-Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women. Clin Infect Dis. 2015 May 15; 60(10):1559-68.
  4. Massad LS, Xie X, D'Souza G, Darragh TM, Minkoff H, Wright R, Colie C, Sanchez-Keeland L, Strickler HD. Incidence of cervical precancers among HIV-seropositive women. Am J Obstet Gynecol. 2015 May; 212(5):606.e1-8.
  5. Stewart Massad L, D'Souza G, Darragh TM, Minkoff H, Wright R, Kassaye S, Sanchez-Keeland L, Evans CT. Accuracy of colposcopy in HIV seropositive and seronegative women with abnormal Pap tests. Gynecol Oncol. 2014 Dec; 135(3):481-6.
  6. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE. Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men. J Clin Microbiol. 2014 Aug; 52(8):2892-7.
  7. Crothers BA, Booth CN, Darragh TM, Zhao C, Souers RJ, Thomas N, Moriarty AT. False-positive Papanicolaou (PAP) test rates in the College of American Pathologists PAP education and PAP proficiency test programs: evaluation of false-positive responses of high-grade squamous intraepithelial lesion or cancer to a negative reference diagnosis. Arch Pathol Lab Med. 2014 May; 138(5):613-9.
  8. Darragh TM, Wilbur DC. Letter to the editor - reply. J Low Genit Tract Dis. 2014 Apr; 18(2):E64-5.
  9. Massad LS, Xie X, Minkoff H, Darragh TM, D'Souza G, Sanchez-Keeland L, Watts DH, Colie C, Strickler HD. Abnormal pap tests and human papillomavirus infections among HIV-infected and uninfected women who have sex with women. J Low Genit Tract Dis. 2014 Jan; 18(1):50-6.
  10. Sharma R, Efird JT, Chein A, Holly EA, Krajden M, Berry JM, Darragh TM, Jay N, Palefsky JM. Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men. J Acquir Immune Defic Syndr. 2013 Dec 15; 64(5):479-87.
  11. Darragh TM, Winkler B, Souers RJ, Laucirica R, Zhao C, Moriarty AT. Room for improvement: initial experience with anal cytology: observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology. Arch Pathol Lab Med. 2013 Nov; 137(11):1550-4.
  12. Massad LS, Pierce CB, Minkoff H, Watts DH, Darragh TM, Sanchez-Keeland L, Wright RL, Colie C, D'Souza G. Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection. Int J Cancer. 2014 Apr 15; 134(8):1854-61.
  13. Berry JM, Jay N, Cranston RD, Darragh TM, Holly EA, Welton ML, Palefsky JM. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer. 2014 Mar 1; 134(5):1147-55.
  14. Howell LP, Darragh TM, Souers RJ, Thomas N, Moriarty AT. Identification of Trichomonas vaginalis in different Papanicolaou test preparations: trends over time in the College of American Pathologists educational Interlaboratory Comparison Program. Arch Pathol Lab Med. 2013 Aug; 137(8):1043-6.
  15. Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N. Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. J Infect Dis. 2013 Dec 1; 208(11):1768-75.
  16. Hessol NA, Holly EA, Efird JT, Minkoff H, Weber KM, Darragh TM, Burk RD, Strickler HD, Greenblatt RM, Palefsky JM. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS. 2013 Jul 17; 27(11):1743-51.
  17. Moscicki AB, Ma Y, Farhat S, Darragh TM, Pawlita M, Galloway DA, Shiboski S. Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16. J Infect Dis. 2013 Aug 1; 208(3):403-12.
  18. Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee JY, Darragh TM, Da Costa M, Panther L, Aboulafia D, Palefsky JM. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women. AIDS. 2013 Feb 20; 27(4):545-51.
  19. Wilbur DC, Darragh TM. Harmony at LAST. Cancer Cytopathol. 2013 Mar; 121(3):111-5.
  20. Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013 Jan; 32(1):76-115.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.